Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05860_nanopub.RAQ9DlHs5tqh8bh2ueu9dyegjEtWuS4koj9nCnwU9if40#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05860 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05860 label "PEG-Infergen [drugbank:DB05860]" assertion.
- drugbank:DB05860 seeAlso DB05860 assertion.
- drugbank:DB05860 description "PEGylation is a technology for the chemical attachment of polyethylene glycol (PEG) polymer chains to a broad range of drug substances such as peptides and proteins including antibody fragments; small molecules, and other drugs. Infergen is a bio-engineered type I interferon alpha that is FDA-approved for the treatment of patients with chronic hepatitis C infections." assertion.
- drugbank:DB05860 identifier "drugbank:DB05860" assertion.
- drugbank:DB05860 title "PEG-Infergen" assertion.
- drugbank:DB05860 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05860 drugbank_vocabulary:drugbank-id "DB05860" assertion.
- drugbank:DB05860 bio2rdf_vocabulary:x-identifiers.org DB05860 assertion.
- drugbank:DB05860 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05860" assertion.
- drugbank:DB05860 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05860 bio2rdf_vocabulary:identifier "DB05860" assertion.